Effect of hawthorn standardized extract on flow mediated dilation in prehypertensive and mildly hypertensive adults: A randomized, controlled cross-over trial

Department of Family Medicine, University of North Carolina, Chapel Hill, USA.
BMC Complementary and Alternative Medicine (Impact Factor: 2.02). 03/2012; 12(1):26. DOI: 10.1186/1472-6882-12-26
Source: PubMed


Hawthorn extract has been used for cardiovascular diseases for centuries. Recent trials have demonstrated its efficacy for the treatment of heart failure, and the results of several small trials suggest it may lower blood pressure. However, there is little published evidence to guide its dosing. The blood pressure lowering effect of hawthorn has been linked to nitric oxide-mediated vasodilation. The aim of this study was to investigate the relationship between hawthorn extract dose and brachial artery flow mediated dilation (FMD), an indirect measure of nitric oxide release.
We used a four-period cross-over design to evaluate brachial artery FMD in response to placebo or hawthorn extract (standardized to 50 mg oligomeric procyanidin per 250 mg extract). Randomly sequenced doses of hawthorn extract (1000 mg, 1500 mg, and 2500 mg) and placebo were assigned to each participant. Doses were taken twice daily for 3 1/2 days followed by FMD and a 4-day washout before proceeding to the next dosing period.
Twenty-one prehypertensive or mildly hypertensive adults completed the study. There was no evidence of a dose-response effect for our main outcome (FMD percent) or any of our secondary outcomes (absolute change in brachial artery diameter and blood pressure). Most participants indicated that if given evidence that hawthorn could lower their blood pressure, they would be likely to use it either in conjunction with or instead of lifestyle modification or anti-hypertensive medications.
We found no evidence of a dose-response effect of hawthorn extract on FMD. If hawthorn has a blood pressure lowering effect, it is likely to be mediated via an NO-independent mechanism.
This trial has been registered with, a service of the U.S. National Institutes of Health: NCT01331486.

Download full-text


Available from: Melissa C Caughey, Oct 01, 2015
20 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Macronutrient and micronutrient deficiencies are very common in the general population, and may be even more common in patients with hypertension and cardiovascular disease due to genetic and environmental causes, and prescription drug use. Vascular biology assumes a pivotal role in the initiation and perpetuation of hypertension and target organ damage sequelae. Endothelial activation, oxidative stress and vascular smooth muscle dysfunction (hypertrophy, hyperplasia and remodeling) are initial events that initiate hypertension. Nutrient-gene interactions determine a broad array of phenotypic consequences such as vascular problems and hypertension. Optimal nutrition, nutraceuticals, vitamins, antioxidants, minerals, weight loss, exercise, smoking cessation, and moderate restriction of alcohol and caffeine, in addition to other lifestyle modifications, can prevent, delay the onset, reduce the severity, treat and control hypertension in many patients. An integrative approach combining these lifestyle suggestions with the correct pharmacologic treatment will best achieve new goal blood pressure levels, reduce cardiovascular risk factors, improve vascular health, reduce target organ damage, including coronary heart disease, stroke, congestive heart failure and renal disease, and reduce healthcare expenditure. The expanded scientific roles for nutraceutical supplements will be discussed in relation to the prevention and treatment of essential hypertension and cardiovascular diseases.
    Expert Review of Cardiovascular Therapy 06/2010; 8(6):821-33. DOI:10.1586/erc.10.63
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hawthorn (Crataegus oxyacantha) is a widely used Chinese herb for treatment of gastrointestinal ailments and heart problems and consumed as food. In North America, the role of treatment for heart problems dates back to 1800. Currently, evidence is accumulating from various in vivo and in vitro studies that hawthorn extracts exert a wide range of cardiovascular pharmacological properties, including antioxidant activity, positive inotropic effect, anti-inflammatory effect, anticardiac remodeling effect, antiplatelet aggregation effect, vasodilating effect, endothelial protective effect, reduction of smooth muscle cell migration and proliferation, protective effect against ischemia/reperfusion injury, antiarrhythmic effect, lipid-lowering effect and decrease of arterial blood pressure effect. On the other hand, reviews of placebo-controlled trials have reported both subjective and objective improvement in patients with mild forms of heart failure (NYHA I-III), hypertension, and hyperlipidemia. This paper discussed the underlying pharmacology mechanisms in potential cardioprotective effects and elucidated the clinical applications of Crataegus and its various extracts.
    Evidence-based Complementary and Alternative Medicine 12/2013; 2013(4):149363. DOI:10.1155/2013/149363 · 1.88 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Macronutrient and micronutrient deficiencies are frequently found in subjects with cardiac disease, vascular problems, hypertension and dyslipidemia as a result of genetic-environmental interactions, and prescription and over-the-counter drug use. The impact on cardiovascular outcomes and healthcare costs is large. The diagnosis and treatment of these nutrient deficiencies may improve endothelial dysfunction and vascular disease and lower blood pressure. Vascular biology with endothelial activation, inflammation oxidative stress and immune dysfunction of arteries are early events in hypertension-related vascular disease. Proper nutrition, nutraceuticals, vitamins, weight management, exercise and other lifestyle changes, are effective in the management of hypertension in most patients. A combinination of drugs with these lifestyle treatments reduce cardiovascular disease. The new scientific role for nutraceuticals and nutrition in the treatment of essential hypertension are reviewed in this article.
    Clinical Practice 03/2013; 10(2):209-229. DOI:10.2217/cpr.13.2
Show more